Stockreport

Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data [Yahoo! Finance]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF SAN MATEO, Calif., June 24, 2024 BUSINESS WIRE Helix , a leading population genomics company and provider of precision medicine genomics solutions, today announced a gr [Read more]